Oncodesign Services (ODS), a CRO specialized in drug discovery and preclinical services, announces its acquisition of ZoBio, a Dutch CRO expert in biophysics-based small molecule drug discovery.
This acquisition allows ODS to strengthen and extend its expertise and capabilities in the field of small molecule discovery to a fully integrated offering to support its customers' innovative programs from target validation to candidate selection.
ODS is notably well recognized for its expertise in preclinical evaluation of experimental therapies in major disease areas such as oncology and immuno-inflammation, as well as its expertise in medicinal chemistry, computational chemistry, DMPK, pharmaco-imaging and molecular radiotherapy. The company has succeeded in developing several drug candidates that have reached the clinical development phase together with its partner clients.
Founded more than 19 years ago, ZoBio has developed a reputation for scientific excellence and innovation in the field of biophysics-based drug discovery. With its best-in-class platform of protein sciences, biophysical and functional assays, structural biology and a unique well diversified small molecule fragment library, ZoBio has helped its clients bring multiple compounds to the clinic.
With this transaction, ODS and ZoBio jointly represent nearly 280 employees spread across Dijon and Les Ulis in France, Leiden in Netherlands and with subsidiaries in Canada and the United States. The deal creates the foundation for ODS's ambition to become a European leader in Drug Discovery by offering fully integrated drug discovery services and solutions, placing quality, scientific creativity, operational excellence and transparent client relationships at the heart of its strategy and investing in innovative technologies.
We are all very excited to welcome ZoBio to the Group, and thus strengthen our offering in small molecule drug discovery preclinical services from Gene-to-IND with leading-edge skills and technologies.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!